Researchers compared how Pseudomonas aeruginosa bacteria form biofilms (protective clusters) in lung samples from cystic fibrosis patients versus in laboratory culture dishes. They found that the bacteria behave quite differently in the lab compared to in patients’ lungs, suggesting that laboratory tests may not accurately predict how well antibiotics will work in real patients. This highlights the importance of studying bacteria directly from patient samples to better understand how infections actually develop and progress.